“…It includes cases with equivocal features of PTC (Fig. 3), features suggestive of chronic thyroiditis and malig- ciently select patients with thyroid nodules for surgery because the risk of malignancy of follicular neoplasm was within the range of baseline risk of malignancy, which was estimated to be about 10-20% in Western countries and 12.4-15.9% in Japan [6,7,[37][38][39][40]. Among a series of 1044 surgically treated patients at Kuma Hospital, Kobe, Japan, in 2000, Mori et al reported that the risk of FTC was 7.9% (22/279) in cases with nodular thyroid diseases (other types of malignancy were excluded) and incidental PTC was found in 7.2% (20/277) of patients with benign nodular disease, with the total risk of malignancy (risk of FTC in index nodule and risk of incidental PTC) in patients with a thyroid nodule (other types of malignancy were excluded) being 14.0% (42/299) [39].…”